PARSABIV is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Etelcalcetide Hydrochloride.
Product ID | 55513-742_012ce6ec-5707-49fa-9e39-6932948c2283 |
NDC | 55513-742 |
Product Type | Human Prescription Drug |
Proprietary Name | PARSABIV |
Generic Name | Etelcalcetide |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2017-04-03 |
Marketing Category | NDA / NDA |
Application Number | NDA208325 |
Labeler Name | Amgen Inc |
Substance Name | ETELCALCETIDE HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/2mL |
Pharm Classes | Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-04-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208325 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-04-03 |
Marketing Category | NDA |
Application Number | NDA208325 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-04-03 |
Ingredient | Strength |
---|---|
ETELCALCETIDE HYDROCHLORIDE | 10 mg/2mL |
SPL SET ID: | cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55513-740 | PARSABIV | etelcalcetide |
55513-741 | PARSABIV | etelcalcetide |
55513-742 | PARSABIV | etelcalcetide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PARSABIV 87038725 5438851 Live/Registered |
Amgen Inc. 2016-05-16 |
PARSABIV 86523783 5428730 Live/Registered |
Amgen Inc. 2015-02-04 |